SEC Form 4 · accession 0001127602-16-067702
MERIDIAN BIOSCIENCE INC · VIVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Eberly
Officer — EVP; Pres, Chief Comm Officer
Period of report
Nov 16, 2016
Accepted (ET)
Nov 18, 2016 · 10:07 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000794172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 16, 2016 | S | 4,926 | $17.003 | D | 48,719 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Prices range from $17.05 per share to $17.001 per share. The reporting person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer.